Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis

Ljungberg, 2007, Prognostic markers in renal cell carcinoma, Curr Opin Urol, 17, 303, 10.1097/MOU.0b013e328277f180 Siegel, 2013, Cancer statistics, 2013, CA Cancer J Clin, 63, 11, 10.3322/caac.21166 Campbell, 2003, Nephrectomy in metastatic renal cell carcinoma, Curr Treat Options Oncol, 4, 363, 10.1007/s11864-003-0037-4 Gao, 2015, Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models, Cell Biochem Biophys, 71, 757, 10.1007/s12013-014-0260-6 Cohen, 2005, Renal-cell carcinoma, N Engl J Med, 353, 2477, 10.1056/NEJMra043172 Rini, 2009, Renal cell carcinoma, Lancet, 373, 1119, 10.1016/S0140-6736(09)60229-4 Pavlidou, 2011, Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR, World J Gastroenterol, 17, 1614, 10.3748/wjg.v17.i12.1614 Takai, 2002, Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma, Cancer Lett, 184, 105, 10.1016/S0304-3835(02)00190-8 Monzo, 1999, A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers, J Clin Oncol, 17, 2100, 10.1200/JCO.1999.17.7.2100 Mita, 2008, Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics, Clin Cancer Res, 14, 5000, 10.1158/1078-0432.CCR-08-0746 Virrey, 2008, Increased survivin expression confers chemoresistance to tumor-associated endothelial cells, Am J Pathol, 173, 575, 10.2353/ajpath.2008.071079 Lo Muzio, 2001, Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma, Exp Mol Pathol, 70, 249, 10.1006/exmp.2001.2367 Athanassiadou, 2008, The prognostic significance of COX-2 and survivin expression in ovarian cancer, Pathol Res Pract, 204, 241, 10.1016/j.prp.2007.11.004 Shi, 2015, Expression of vimentin and survivin in clear cell renal cell carcinoma and correlation with p53, Clin Transl Oncol, 17, 65, 10.1007/s12094-014-1199-1 Weber, 2013, Immunohistochemical analysis of prognostic protein markers for primary localized clear cell renal cell carcinoma, Cancer Invest, 31, 51, 10.3109/07357907.2012.749267 Lei, 2010, Prognostic significance of survivin expression in renal cell cancer and its correlation with radioresistance, Mol Cell Biochem, 344, 23, 10.1007/s11010-010-0525-3 Parker, 2009, Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma, Cancer, 115, 2092, 10.1002/cncr.24263 Zamparese, 2008, Survivin expression in renal cell carcinoma, Cancer Invest, 26, 929, 10.1080/07357900802017553 Dornbusch, 2013 Simon, 2009, Use of archived specimens in evaluation of prognostic and predictive biomarkers, J Natl Cancer Inst, 101, 1446, 10.1093/jnci/djp335 Liu, 2014, Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma, Tumour Biol, 35, 8281, 10.1007/s13277-014-2058-y Krambeck, 2007, Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma, Clin Cancer Res, 13, 1749, 10.1158/1078-0432.CCR-06-2129 Byun, 2007, Expression of survivin in renal cell carcinomas: association with pathologic features and clinical outcome, Urology, 69, 34, 10.1016/j.urology.2006.09.024 Kosari, 2005, Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness, Clin Cancer Res, 11, 5128, 10.1158/1078-0432.CCR-05-0073 Wang, 2009, Expression of cortactin and survivin in renal cell carcinoma associated with tumor aggressiveness, World J Urol, 27, 557, 10.1007/s00345-009-0376-2 Lu, 2009, Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance, Clin Cancer Res, 15, 1326, 10.1158/1078-0432.CCR-08-0954 Andersen, 2007, The universal character of the tumor-associated antigen survivin, Clin Cancer Res, 13, 5991, 10.1158/1078-0432.CCR-07-0686 Hernandez, 2011, Expression of the antiapoptotic protein survivin in colon cancer, Clin Colorectal Cancer, 10, 188, 10.1016/j.clcc.2011.03.014 Hsu, 2012, Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells, Biochim Biophys Acta, 1820, 104, 10.1016/j.bbagen.2011.11.011 Mahalingam, 2010, Vorinostat enhances the activity of temsirolimus in renal cell carcinoma through suppression of survivin levels, Clin Cancer Res, 16, 141, 10.1158/1078-0432.CCR-09-1385